- Trump's trade policies and immigration have impacted the economy, and hypothetical conflict could disrupt global energy markets.
- Policy decisions concerning tariffs and economic investment related to Jay's economic revival.
- Aggressive tariff plan announced in April 2025 involving Trump and market implications.
Clarivate stock was downgraded by Jefferies amid discussions of Trump tariffs and NIH funding cuts.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Clarivate stock was downgraded by Jefferies amid discussions of Trump tariffs and NIH funding cuts.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Aggressive tariff plan announced in April 2025 involving Trump and market implications.Also in this story
- Arvinas stock benefits from Trump-era tariffs following the EHA 2025 Congress held in Milan, Italy.
- Trump's aggressive tariff plan, announced in April 2025, affects various companies including Market, Astec, HPQ, and LADR, which are involved in manufacturing, technology, and real estate.
- Power Integrations and Compass operate in the US market while Trump's aggressive tariff plan is active.
- Trump unveiled an aggressive tariff plan involving ASGN.
The entities involved
-
National Institutes of Health
government organization in Shah Alam, Malaysia
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Clarivate
American analytics company
Nothing else this week.
Related events
- Donald Trump proposed significant budget cuts to the National Science Foundation.
- NIH cuts budgets and personnel, impacting funded research leading to FDA-approved treatments.
- Trump's tariff plan caused markets to tank, impacting Donnelley Financial Solutions.
- AI stocks are benefiting from Trump-era tariffs, and Brian Schwartz maintained an Outperform rating on Workday on September 5th.
- Barclays raised its price target for Okta, noting that AI stocks are benefiting from the onshoring trend and Trump-era tariffs.
Coverage
Newest first; wire copies grouped- Insider MonkeyJefferies Downgrades Clarivate (CLVT) to Hold From Buy, Brings PT Down to $4.50 Clarivate Plc (NYSE:CLVT) is one of the best affordable stocks under $5 to invest in. On July 18, Jefferies downgraded